⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Data 1 from Targeting BCL2 overcomes resistance and augments response to aurora kinase B inhibition by AZD2811 in small cell lung cancer

Kavya Ramkumar Azusa Tanimoto Carminia M. Della Corte C. Allison Stewart Qi Wang Li Shen Robert J. Cardnell Jing Wang Urszula M. Polanska Courtney L. Andersen Jamal Saeh J. Elizabeth Pease Jon Travers Giulia Fabbri Carl M. Gay Jelena Urosevic Lauren A. Byers

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary table shows AZD2811 sensitivity, transcriptomic and proteomic profiles of SCLC cell lines

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ramkumar et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db6435875226fc https://doi.org/10.1158/1078-0432.27032248

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Data 1 from Targeting BCL2 overcomes resistance and augments response to aurora kinase B inhibition by AZD2811 in small cell lung cancer2024
2Supplementary Figure 1 from Targeting BCL2 overcomes resistance and augments response to aurora kinase B inhibition by AZD2811 in small cell lung cancer2024
3Supplementary Figure 1 from Targeting BCL2 overcomes resistance and augments response to aurora kinase B inhibition by AZD2811 in small cell lung cancer2024
4Supplementary Figure 4 from Targeting BCL2 overcomes resistance and augments response to aurora kinase B inhibition by AZD2811 in small cell lung cancer2024
5Supplementary Figure 4 from Targeting BCL2 overcomes resistance and augments response to aurora kinase B inhibition by AZD2811 in small cell lung cancer2024